Latest Breaking News On - Aasma shaukat - Page 1 : comparemela.com

Blood-Based Test for CRC Screening Hits Sensitivity, Specificity Endpoints

Test could fill a gap in CRC screening

Blood-Based Test Offers Effective Screening Option for Colorectal Cancer

Data from PREEMPT CRC reveal the blood-based screening test demonstrated a 79.2% sensitivity for detecting colorectal cancer.

Blood-based screening test detects CRC with nearly 80% sensitivity in average-risk adults

WASHINGTON — A blood-based screening test detected colorectal cancer with a sensitivity of 79.2% and a specificity of 91.5% among average-risk adults aged 45 to 85 years, according to research presented at Digestive Disease Week. “Adherence to colon cancer screening tests is suboptimal with current options of stool-based tests and colonoscopy,” Aasma Shaukat, MD, MPH, director

Reality Check: Data on Blood-Based Colorectal Cancer Screening

CRC: Next-Generation mt-sDNA Test Beats FIT for Sensitivity

A next-generation multitarget stool DNA test for colorectal cancer screening had higher sensitivity but lower specificity than a currently available FIT, according to the large prospective BLUE-C study.